| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Bhalla Narinder Pal serves as a Chief Medical Officer at LXEO. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $304K at current prices.
The biggest single holding is LXEO (~$304K) as Chief Medical Officer. The recent filings there lean toward selling, a net 22,306 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | LXEO Lexeo Therapeutics, Inc. | Chief Medical Officer | Sell | 22,306 | $4.42 | $98,592.52 | -21.3% |